Kitov Pharmaceuticals Hldgs L Sponsored ADR (KTOV)

[salgovernale69]

Regarding the shelf registration, it's worth noting that when I spoke to Bob Yedid of Life Sci Capital, their new IR and Advisory firm, he made the comment that a shelf offering for biotechs is a best practice and they highly recommend for all their clients. This came up when I was grilling him on the authorized share count increase; he essentially said it was meaningless and something all companies do and only want to do once. That's when he made the comparison of shelf filings being a best practice that they recommend but it doesn't mean a company intends to dilute.

I think the shelf is a good thing, all bios should have it in place to be ready for price appreciation. They have the option to do an offering quickly when price is high, ability to issue shares to a partner, etc. However, I'm guessing Life Sci encouraged them to put this in place. I didn't think much of Bob's comment at the time but it's the first thing I thought of when I saw the filing.